A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of HLX319 vs. EU-Phesgo® in the Neoadjuvant Therapy of HER2-Positive Early or Locally Advanced Breast Cancer
PHASE1
This is a study to compare the similarity in Pharmacokinetics (PK) profile ...
Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer
PHASE3
To compare the efficacy and safety of PERT-IJS (Proposed biosimilar Pertuzu...
Efficacy and Safety Study of EG1206A (EirGenix' Pertuzumab) Compared With EU-sourced Perjeta® (Pertuzumab) in Patients With HER2-positive Hormone Receptor Negative Early Breast Cancer.
PHASE3
The purpose of this research study is to compare the efficacy and safety of...
Status
Withdrawn
Location
Methodist Health System Clinical Research Institute
A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer
PHASE3
This is a phase III, double-blind, randomized, parallel-controlled, multice...
Status
Active Not Recruiting
Location
the First Affiliated Hospital of Bengbu Medical College